Haemonetics Corporation Releases Q1 2026 Financial Results
Haemonetics Corporation Financial Results Release
Haemonetics Corporation (NYSE: HAE) has made its latest financial results for the first quarter of fiscal year 2026 accessible on its Investor Relations website. This announcement showcases the company's achievements and progress over the past quarter.
Conference Call Details
To discuss the financial results, Haemonetics will be hosting a conference call and webcast aimed at investors and analysts. This session is scheduled for 8:00 a.m. ET, and it will provide an opportunity to delve into the results and engage with the company's leadership.
Access Information
Participants can obtain dial-in details upon registration, with a recommendation to join the call approximately ten minutes early. The live conference will be available through a designated link on the company's Investor Relations page.
Review of Earnings Release
An earnings release outlining the key financials referenced during the conference call can be found on the Investor Relations website. This document will provide additional insights into the company's performance metrics and strategic initiatives.
Replay of the Conference Call
For those who are unable to attend the live event, a replay of the conference call and webcast will be available for one year from the date of the event starting at 11:00 a.m. ET. This allows stakeholders to stay informed and engaged with the company's developments.
About Haemonetics Corporation
Haemonetics is a world leader in medical technology, focusing on enhancing the efficiency and effectiveness of healthcare delivery. The company provides innovative solutions designed to address critical healthcare challenges. With a comprehensive suite of products and services ranging from hospital technologies to plasma collection, Haemonetics is dedicated to improving patient outcomes.
Investor Relations Contacts
For further inquiries, the following contacts are available:
Olga Guyette
Vice President-Investor Relations & Treasury
(781) 356-9763
olga.guyette@haemonetics.com
David Trenk
Manager-Investor Relations
(203) 733-4987
david.trenk@haemonetics.com
Media Contact
Josh Gitelson
Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com
Frequently Asked Questions
What did Haemonetics Corporation recently announce?
Haemonetics Corporation announced their financial results for Q1 of fiscal year 2026, which are now available on their Investor Relations website.
When is the conference call scheduled?
The conference call is set for 8:00 a.m. ET, providing a platform for investors and analysts to discuss the financial outcomes.
Can I access a replay of the conference call?
Yes, the replay will be available for one year after the event for anyone who missed the live session.
How can I learn more about Haemonetics Corporation?
To learn more about their initiatives and healthcare solutions, visit Haemonetics' official website.
Who should I contact for more information about investor relations?
You can contact Olga Guyette or David Trenk for investor relations inquiries or reach out to Josh Gitelson for media-related questions.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.